Transgene : Inside Information / Other news releases

P R E S S R E L E A S E


Transgene - First Patient Dosed in Phase I Trial Evaluating TG6050, a Novel IL-12-Armed Oncolytic Virus Administered... | May 10, 2023

Related Keywords

United States ,France ,Copenhagen ,Køavn ,Denmark ,American ,Maud Brandely ,Transgene Euronext ,Sylvie Berrebi ,Lucie Larguier ,Corporate Communications ,Twitter ,American Association For Cancer Research ,Patient Dosed ,Phasei Trial Evaluating ,Armed Oncolytic Virus Administered Intravenously ,Non Small Cell Lung Cancer ,Phasei Delivir ,Euronext Paris ,Chief Medical Officer ,American Association ,Cancer Research ,Annual Meeting ,Artificial Intelligence ,Risk Factors ,Universal Registration Document ,Transgene Stock Exchange ,News ,Information ,Press Release , ,Transgene ,First ,Patient ,Hosed ,N ,Hase ,Trial ,Valuating ,Novel ,Ncolytic ,Irus Tng Fr0005175080 ,